IDEAYA Biosciences Inc
NASDAQ:IDYA

Watchlist Manager
IDEAYA Biosciences Inc Logo
IDEAYA Biosciences Inc
NASDAQ:IDYA
Watchlist
Price: 17.44 USD -3.16% Market Closed
Market Cap: 1.5B USD
Have any thoughts about
IDEAYA Biosciences Inc?
Write Note

Wall Street
Price Targets

IDYA Price Targets Summary
IDEAYA Biosciences Inc

Wall Street analysts forecast IDYA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDYA is 52.88 USD with a low forecast of 27.27 USD and a high forecast of 66.15 USD.

Lowest
Price Target
27.27 USD
56% Upside
Average
Price Target
52.88 USD
203% Upside
Highest
Price Target
66.15 USD
279% Upside
IDEAYA Biosciences Inc Competitors:
Price Targets
BNTX
BioNTech SE
45% Upside
BSLN
Basilea Pharmaceutica AG
80% Upside
145020
Hugel Inc
18% Upside
300685
Amoy Diagnostics Co Ltd
35% Upside
GNLX
Genelux Corp
487% Upside
GNS
Genus PLC
27% Upside
RYTM
Rhythm Pharmaceuticals Inc
41% Upside
APGE
Apogee Therapeutics Inc
138% Upside

Revenue
Forecast

Revenue Estimate
IDEAYA Biosciences Inc

The compound annual growth rate of IDEAYA Biosciences Inc's revenue for the next 3 years is 190%.

N/A
Past Growth
190%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
IDEAYA Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
IDEAYA Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDYA's stock price target?
Price Target
52.88 USD

According to Wall Street analysts, the average 1-year price target for IDYA is 52.88 USD with a low forecast of 27.27 USD and a high forecast of 66.15 USD.

What is IDEAYA Biosciences Inc's Revenue forecast?
Projected CAGR
190%

The compound annual growth rate of IDEAYA Biosciences Inc's revenue for the next 3 years is 190%.

Back to Top